Approval · Notice of Compliance 29430 · 2022
VASERETIC: Notice of Compliance 29430
Issued November 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29430
- Date
- November 7, 2022
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add the risk of acute respiratory distress syndrome to the WARNINGS and PRECAUTIONS and the Post-market adverse reaction sections of the Product Monograph (PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASERETIC | Not yet assigned | — |
Medicinal ingredients
- ENALAPRIL MALEATE 10 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB